August 29, 2019

4Children Lesotho completed this learning brief to document the experience of transitioning a large USAID-funded orphans and vulnerable children (OVC) project from one USAID grantee to another. In the past several years, PEPFAR countries have transitioned OVC programs to new partners or new geogr

August 23, 2019

Background: HIV acquisition remains high among adolescent girls and young women (AGYW, aged 15–24 years) in sub-Saharan Africa.

July 30, 2019

mothers2mothers (m2m) is an African NGO working towards the Global Goals of ensuring good health for all and ending the AIDS epidemic by 2030.

July 16, 2019

Have you been looking for an easier and more accurate way to quantify pediatric HIV treatment needs over time?

May 27, 2019

The USAID/TSP HIV Child and Adolescent ARV Procurement Forecasting Tool is intended to assist program managers, clinicians and support staff in quantifying and budgeting for a program’s child and adolescent ARV needs.

May 12, 2019
In our 8th issue of our Research Digest, we have assembled 64 abstracts published from March through April 2019 that feature evidence from Botswana (2), Eswatini (2), Lesotho (2), Malawi (12), Mozambique (4), Namibia (1), South Africa (32), Tanzania (3), Zambia (11) and Zimbabwe (14).
April 12, 2019

Stigma and discrimination affecting lesbian, gay, bisexual, and transgender (LGBT) people compromise health and human rights and exacerbate the HIV epidemic. Scant research has explored effective LGBT stigma reduction strategies in low- and middle-income countries.

April 2, 2019
In this, our 7th, issue, we have assembled 67 abstracts published from January through February 2019 that feature evidence from Botswana (3), Eswatini (2), Lesotho (2), Malawi (16), Mozambique (3), South Africa (40), Tanzania (2), Zambia (3) and Zimbabwe (7).
March 19, 2019

The U.S. President's Emergency Plan for AIDS Relief (PEPFAR) delivers life-saving services to people affected by the HIV/AIDS epidemic in 36 country and regional programs. Founded in 2003, PEPFAR is the largest investment in combating a single disease by a single country in history.